Remdesivir Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04593940Immune Modulators for Treating COVID-19
NCT04501978ACTIV-3: Therapeutics for Inpatients With COVID-19
NCT04501952Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
NCT04492475Adaptive COVID-19 Treatment Trial 3 (ACTT-3)